Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer

por Pabst, Kim Magaly, Seifert, Robert, Hirmas, Nader, Broecker-Preuss, Martina, Weber, Manuel, Peter Fendler, Wolfgang, Bartel, Timo, Theurer, Sarah, Herrmann, Ken, Görges, Rainer
Publicado 2022

Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Syste...

por Jeschke, Matthias, Ludwig, Johannes M., Leyh, Catherine, Pabst, Kim M., Weber, Manuel, Theysohn, Jens M., Lange, Christian M., Herrmann, Ken, Schmidt, Hartmut H. -J., Jochheim, Leonie S.
Publicado 2023

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer

por Giovanella, Luca, Milan, Lisa, Roll, Wolfgang, Weber, Manuel, Schenke, Simone, Kreissl, Michael, Vrachimis, Alexis, Pabst, Kim, Murat, Tuncel, Petranovic Ovcaricek, Petra, Riemann, Burkhard, Ceriani, Luca, Campenni, Alfredo, Görges, Rainer
Publicado 2023

Safety and Survival Outcomes of (177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior (223)Ra treatment: Th...

por Rahbar, Kambiz, Essler, Markus, Pabst, Kim M., Eiber, Matthias, la Fougère, Christian, Prasad, Vikas, Rassek, Philipp, Hasa, Ergela, Dittmann, Helmut, Bundschuh, Ralph A., Fendler, Wolfgang P., Kurtinecz, Milena, Schmall, Anja, Verholen, Frank, Sartor, Oliver
Publicado 2023

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)

por Rahbar, Kambiz, Essler, Markus, Eiber, Matthias, la Fougère, Christian, Prasad, Vikas, Fendler, Wolfgang P., Rassek, Philipp, Hasa, Ergela, Dittmann, Helmut, Bundschuh, Ralph A., Pabst, Kim M., Kurtinecz, Milena, Schmall, Anja, Verholen, Frank, Sartor, Oliver
Publicado 2023

Safety and Efficacy of (90)Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

por Fendler, Wolfgang P., Pabst, Kim M., Kessler, Lukas, Fragoso Costa, Pedro, Ferdinandus, Justin, Weber, Manuel, Lippert, Maria, Lueckerath, Katharina, Umutlu, Lale, Kostbade, Karina, Mavroeidi, Ilektra A., Schuler, Martin, Ahrens, Marit, Rischpler, Christoph, Bauer, Sebastian, Herrmann, Ken, Siveke, Jens T., Hamacher, Rainer
Publicado 2022

Superior Tumor Detection for (68)Ga-FAPI-46 Versus (18)F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

por Pabst, Kim M., Trajkovic-Arsic, Marija, Cheung, Phyllis F.Y., Ballke, Simone, Steiger, Katja, Bartel, Timo, Schaarschmidt, Benedikt M., Milosevic, Aleksandar, Seifert, Robert, Nader, Michael, Kessler, Lukas, Siveke, Jens T., Lueckerath, Katharina, Kasper, Stefan, Herrmann, Ken, Hirmas, Nader, Schmidt, Hartmut H., Hamacher, Rainer, Fendler, Wolfgang P.
Publicado 2023